Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk

References

[1] Amati F, Pennant M, Azuma K, Dube JJ, Toledo FG, Rossi AP, et al. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity. 2012;20:1115–7.10.1038/oby.2011.401Suche in Google Scholar

[2] Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–49.10.1161/ATVBAHA.107.159228Suche in Google Scholar

[3] Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J clin Invest. 1983;72:1150–62.10.1172/JCI111040Suche in Google Scholar

[4] Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39–48.10.1161/CIRCULATIONAHA.106.675355Suche in Google Scholar

[5] Karelis AD. Metabolically healthy but obese individuals. Lancet. 2008;372:1281–3.10.1016/S0140-6736(08)61531-7Suche in Google Scholar

[6] Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–16.10.1001/archinte.168.15.1609Suche in Google Scholar PubMed

[7] Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168:1617–24.10.1001/archinte.168.15.1617Suche in Google Scholar PubMed

[8] Huang LO, Loos R, Kilpelainen TO. Evidence of genetic predisposition for metabolically healthy obesity and metabolically obese normal weight. Physiol Genomics. 2017. Epub Dec 20.10.1152/physiolgenomics.00044.2017Suche in Google Scholar PubMed PubMed Central

[9] Kang YM, Jung CH, Cho YK, Jang JE, Hwang JY, Kim EH, et al. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. PLoS One. 2017;12. Epub June 23.10.1371/journal.pone.0179635Suche in Google Scholar PubMed PubMed Central

[10] Heianza Y, Arase Y, Tsuji H, Fujihara K, Saito K, Hsieh SD, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J Clin Endocrinol Metab. 2014;99:2952–60.10.1210/jc.2013-4427Suche in Google Scholar PubMed

[11] Hashimoto Y, Hamaguchi M, Tanaka M, Obora A, Kojima T, Fukui M. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Res Clin Pract. 2018. Epub Jan 22.10.1016/j.orcp.2017.12.003Suche in Google Scholar PubMed

[12] Banerji MA, Lebowitz J, Chaiken RL, Gordon D, Kral JG, Lebovitz HE. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol. 1997;273(2 Pt 1):E425–32.10.1152/ajpendo.1997.273.2.E425Suche in Google Scholar PubMed

[13] Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2002;283:E1135–43.10.1152/ajpendo.0327.2001Suche in Google Scholar PubMed

[14] Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133:496–506.10.1053/j.gastro.2007.04.068Suche in Google Scholar PubMed

[15] Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab. 2002;282:E657–63.10.1152/ajpendo.00469.2001Suche in Google Scholar PubMed

[16] Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549–57.10.1056/NEJMoa033179Suche in Google Scholar PubMed

[17] Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002;26:193–9.10.1038/sj.ijo.0801871Suche in Google Scholar PubMed

[18] Fabbrini E, Tamboli RA, Magkos F, Marks-Shulman PA, Eckhauser AW, Richards WO, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139:448–55.10.1053/j.gastro.2010.04.056Suche in Google Scholar PubMed PubMed Central

[19] Auclair A, Martin J, Bastien M, Bonneville N, Biertho L, Marceau S, et al. Is there a role for visceral adiposity in inducing type 2 diabetes remission in severely obese patients following biliopancreatic diversion with duodenal switch surgery? Obes Surg. 2016;26:1717–27.10.1007/s11695-015-1973-3Suche in Google Scholar PubMed

[20] Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008;87:1212–8.10.1093/ajcn/87.5.1212Suche in Google Scholar PubMed PubMed Central

[21] Nicklas BJ, Penninx BW, Ryan AS, Berman DM, Lynch NA, Dennis KE. Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care. 2003;26:1413–20.10.2337/diacare.26.5.1413Suche in Google Scholar PubMed

[22] Borel AL, Nazare JA, Smith J, Aschner P, Barter P, Van Gaal L, et al. Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance. Int J Obes (Lond). 2015;39:495–501.10.1038/ijo.2014.163Suche in Google Scholar PubMed

[23] Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Kahn SE, Fujimoto WY. Change in visceral adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care. 2013;36:289–93.10.2337/dc12-0198Suche in Google Scholar PubMed PubMed Central

[24] Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J physiol. 2001;280:E1000–6.10.1152/ajpendo.2001.280.6.E1000Suche in Google Scholar PubMed

[25] Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes. 1996;45:1684–93.10.2337/diab.45.12.1684Suche in Google Scholar PubMed

[26] Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96:88–98.10.1172/JCI118083Suche in Google Scholar PubMed PubMed Central

[27] Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116:1234–41.10.1161/CIRCULATIONAHA.107.710509Suche in Google Scholar PubMed

[28] Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc. 2002;288:2709–16.10.1001/jama.288.21.2709Suche in Google Scholar PubMed

[29] Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.10.2337/diacare.24.4.683Suche in Google Scholar PubMed

[30] DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–94.10.2337/diacare.14.3.173Suche in Google Scholar PubMed

[31] Mongraw-Chaffin M, Allison MA, Burke GL, Criqui MH, Matsushita K, Ouyang P, et al. CT-derived body fat distribution and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab. 2017;102:4173–83.10.1210/jc.2017-01113Suche in Google Scholar PubMed PubMed Central

[32] Sam S, Haffner S, Davidson MH, D’Agostino RB, Sr., Feinstein S, Kondos G, et al. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes. 2008;57:2022–7.10.2337/db08-0157Suche in Google Scholar PubMed PubMed Central

[33] Sam S, Haffner S, Davidson MH, D’Agostino RB, Sr., Feinstein S, Kondos G, et al. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009;32:932–7.10.2337/dc08-1856Suche in Google Scholar PubMed PubMed Central

[34] Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95:5419–26.10.1210/jc.2010-1378Suche in Google Scholar PubMed PubMed Central

[35] Festa A, Williams K, D’Agostino R, Jr., Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006;55:1114–20.10.2337/diabetes.55.04.06.db05-1100Suche in Google Scholar PubMed

[36] Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983;57:304–10.10.1210/jcem-57-2-304Suche in Google Scholar PubMed

[37] Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4:20–34.10.1002/j.1550-8528.1996.tb00536.xSuche in Google Scholar PubMed

[38] Bjorntorp P. Hyperandrogenicity in women – a prediabetic condition? J Inten Med. 1993;234:579–83.10.1111/j.1365-2796.1993.tb01016.xSuche in Google Scholar PubMed

[39] Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007;21:415–30.10.1016/j.beem.2007.04.007Suche in Google Scholar PubMed

[40] Lovejoy JC, Bray GA, Bourgeois MO, Macchiavelli R, Rood JC, Greeson C, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women – a clinical research center study. J Clin Endocrinol Metab. 1996;81:2198–203.10.1210/jcem.81.6.8964851Suche in Google Scholar

[41] Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab. 1997;82:2044–7.10.1210/jc.82.7.2044Suche in Google Scholar

[42] Nordstrom A, Hadrevi J, Olsson T, Franks PW, Nordstrom P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab. 2016;101:3740–6.10.1210/jc.2016-1915Suche in Google Scholar PubMed

[43] Elffers TW, de Mutsert R, Lamb HJ, de Roos A, Willems van Dijk K, Rosendaal FR, et al. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PLoS One. 2017;12:e0185403.10.1371/journal.pone.0185403Suche in Google Scholar PubMed PubMed Central

[44] Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.10.1210/jc.2006-0178Suche in Google Scholar PubMed

[45] Seow KM, Tsai YL, Hwang JL, Hsu WY, Ho LT, Juan CC. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome. Hum Reprod. 2009;24:1982–8.10.1093/humrep/dep122Suche in Google Scholar PubMed

[46] Manneras-Holm L, Leonhardt H, Kullberg J, Jennische E, Oden A, Holm G, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab. 2011;96:E304–11.10.1210/jc.2010-1290Suche in Google Scholar PubMed

[47] Huang ZH, Manickam B, Ryvkin V, Zhou XJ, Fantuzzi G, Mazzone T, et al. PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity. J Clin Endocrinol Metab. 2012;98:E17–24.10.1210/jc.2012-2697Suche in Google Scholar PubMed PubMed Central

[48] Pasquali R, Casimirri F, Cantobelli S, Labate AM, Venturoli S, Paradisi R, et al. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res. 1993;39:179–87.10.1159/000182732Suche in Google Scholar PubMed

[49] Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18:618–37.10.1093/humupd/dms030Suche in Google Scholar PubMed

[50] Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992;41:1257–66.10.2337/diab.41.10.1257Suche in Google Scholar PubMed

[51] Horejsi R, Moller R, Rackl S, Giuliani A, Freytag U, Crailsheim K, et al. Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women. Am J Phys Anthropol. 2004;124:275–81.10.1002/ajpa.10364Suche in Google Scholar PubMed

[52] Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016;101:4178–88.10.1210/jc.2016-2586Suche in Google Scholar PubMed PubMed Central

[53] Mongraw-Chaffin ML, Anderson CA, Allison MA, Ouyang P, Szklo M, Vaidya D, et al. Association between sex hormones and adiposity: qualitative differences in women and men in the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2015;100:E596–600.10.1210/jc.2014-2934Suche in Google Scholar PubMed PubMed Central

[54] Kim C, Dabelea D, Kalyani RR, Christophi CA, Bray GA, Pi-Sunyer X, et al. Changes in visceral adiposity, subcutaneous adiposity, and sex hormones in the diabetes prevention program. J Clin Endocrinol Metab. 2017;102:3381–9.10.1210/jc.2017-00967Suche in Google Scholar PubMed PubMed Central

[55] Lim JS, Choi YJ, Kim SK, Huh BW, Lee EJ, Huh KB. Optimal waist circumference cutoff value based on insulin resistance and visceral obesity in koreans with type 2 diabetes. Diabetes Metab J. 2015;39:253–63.10.4093/dmj.2015.39.3.253Suche in Google Scholar PubMed PubMed Central

[56] Jung SH, Ha KH, Kim DJ. Visceral fat mass has stronger associations with diabetes and prediabetes than other anthropometric obesity indicators among korean adults. Yonsei Med J. 2016;57:674–80.10.3349/ymj.2016.57.3.674Suche in Google Scholar PubMed PubMed Central

[57] Tatsumi Y, Nakao YM, Masuda I, Higashiyama A, Takegami M, Nishimura K, et al. Risk for metabolic diseases in normal weight individuals with visceral fat accumulation: a cross-sectional study in Japan. BMJ Open. 2017;7:e013831.10.1136/bmjopen-2016-013831Suche in Google Scholar PubMed PubMed Central

[58] Jorgensen ME, Borch-Johnsen K, Stolk R, Bjerregaard P. Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care. 2013;36:2988–94.10.2337/dc12-2703Suche in Google Scholar PubMed PubMed Central

[59] Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, et al. Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring). 2009;17:1420–7.10.1038/oby.2008.657Suche in Google Scholar PubMed

[60] Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER. Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr 1999;69:381–7.10.1093/ajcn/69.3.381Suche in Google Scholar PubMed

[61] Okosun IS, Tedders SH, Choi S, Dever GE. Abdominal adiposity values associated with established body mass indexes in white, black and hispanic Americans. A study from the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2000;24:1279–85.10.1038/sj.ijo.0801414Suche in Google Scholar PubMed

[62] Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism. 1996;45:1119–24.10.1016/S0026-0495(96)90011-6Suche in Google Scholar

[63] Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 2007;104:12587–94.10.1073/pnas.0705408104Suche in Google Scholar

[64] Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267–77.10.1016/S0140-6736(10)60408-4Suche in Google Scholar

[65] Preis SR, Massaro JM, Hoffmann U, D’Agostino RB, Sr., Levy D, Robins SJ, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab. 2010;95:3701–10.10.1210/jc.2009-1779Suche in Google Scholar

[66] Lee JJ, Pedley A, Therkelsen KE, Hoffmann U, Massaro JM, Levy D, et al. Upper body subcutaneous fat is associated with cardiometabolic risk factors. Am J Med. 2017;130:958–66 e1.10.1016/j.amjmed.2017.01.044Suche in Google Scholar

[67] Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. Journal Clin Invest. 1991;88:609–13.10.1172/JCI115345Suche in Google Scholar

[68] Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J. 2009;30:850–6.10.1093/eurheartj/ehn573Suche in Google Scholar

[69] Taguchi R, Takasu J, Itani Y, Yamamoto R, Yokoyama K, Watanabe S, et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis. 2001;157:203–9.10.1016/S0021-9150(00)00709-7Suche in Google Scholar

[70] Sato F, Maeda N, Yamada T, Namazui H, Fukuda S, Natsukawa T, et al. Association of epicardial, visceral, and subcutaneous fat with cardiometabolic diseases. Circ J. 2018 Epub 25.10.1253/circj.CJ-17-0820Suche in Google Scholar PubMed

[71] Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605–13.10.1161/CIRCULATIONAHA.107.743062Suche in Google Scholar PubMed

[72] Fang L, Guo F, Zhou L, Stahl R, Grams J. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015;4:273–9.10.1080/21623945.2015.1034920Suche in Google Scholar

[73] Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847–50.10.1210/jc.83.3.847Suche in Google Scholar

[74] Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab. 2005;90:2282–9.10.1210/jc.2004-1696Suche in Google Scholar

[75] Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 1997;46:860–7.10.2337/diab.46.5.860Suche in Google Scholar

[76] Festa A, D’Agostino R, Jr., Williams K, Karter AJ, Mayer-Davis EJ, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25:1407–15.10.1038/sj.ijo.0801792Suche in Google Scholar

[77] Lemieux I, Pascot A, Prud’homme D, Almeras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21:961–7.10.1161/01.ATV.21.6.961Suche in Google Scholar

[78] Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–3.10.2337/db06-1656Suche in Google Scholar

[79] Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S57–63.10.1210/jc.2008-1585Suche in Google Scholar

[80] Arner P. Not all fat is alike. Lancet. 1998;351:1301–2.10.1016/S0140-6736(05)79052-8Suche in Google Scholar

[81] Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996;98:741–9.10.1172/JCI118846Suche in Google Scholar PubMed PubMed Central

[82] Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 2000;11:351–6.10.1016/S1043-2760(00)00323-4Suche in Google Scholar

[83] Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109(21 Suppl 1):II2–10.10.1161/01.CIR.0000129535.04194.38Suche in Google Scholar PubMed

[84] Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc. 1998;279:1477–82.10.1001/jama.279.18.1477Suche in Google Scholar PubMed

[85] Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–43.10.1056/NEJM200003233421202Suche in Google Scholar PubMed

[86] Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003;108:161–5.10.1161/01.CIR.0000080289.72166.CFSuche in Google Scholar PubMed

[87] Park CS, Ihm SH, Yoo KD, Kim DB, Lee JM, Kim HY, et al. Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA. Am J Cardiol. 2010;105:1284–8.10.1016/j.amjcard.2009.12.045Suche in Google Scholar PubMed

[88] Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–9.10.1161/01.CIR.0000080897.52664.94Suche in Google Scholar PubMed

[89] Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.10.1172/JCI200319451Suche in Google Scholar

[90] Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808.10.1172/JCI200319246Suche in Google Scholar

[91] Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Invest. 2007;92:2240–7.10.1210/jc.2006-1811Suche in Google Scholar

[92] Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA. 2009;106:15430–5.10.1073/pnas.0904944106Suche in Google Scholar PubMed PubMed Central

[93] Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094–101.10.1172/JCI45887Suche in Google Scholar PubMed PubMed Central

[94] Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350:1220–34.10.1056/NEJMra025261Suche in Google Scholar PubMed

[95] Ng JM, Azuma K, Kelley C, Pencek R, Radikova Z, Laymon C, et al. PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans. Am J Physiol Endocrinol Metab. 2012;303:E1134–41.10.1152/ajpendo.00282.2012Suche in Google Scholar PubMed PubMed Central

[96] Oliveira AL, Azevedo DC, Bredella MA, Stanley TL, Torriani M. Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects. Obesity (Silver Spring). 2015;23:286–9.10.1002/oby.20957Suche in Google Scholar PubMed PubMed Central

[97] Christen T, Sheikine Y, Rocha VZ, Hurwitz S, Goldfine AB, Di Carli M, et al. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging. 2010;3:843–51.10.1016/j.jcmg.2010.06.004Suche in Google Scholar PubMed PubMed Central

[98] Gealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K, et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation. 2011;123:186–94.10.1161/CIRCULATIONAHA.110.970145Suche in Google Scholar PubMed PubMed Central